Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the American company Second Sight Medical Products. It is used as a visual prosthesis to improve the vision of people with severe cases of retinitis pigmentosa.

The Argus As I was a four-cylinder, water-cooled, aircraft engine produced in Germany by Argus Motoren from 1911 until about 1913. The engine saw widespread use in aircraft in pre-war Germany and initially was also sold under the brand name 'Aviatik' of …

Oct 1, 2016 · Two generations of devices, the Argus I and Argus II, have been developed by SSMP. Argus I is a first-generation epiretinal prosthesis approved for a phase I clinical trial by the United States Food and Drug Administration (FDA) aimed primarily at establishing safety.

Dec 2, 2019 · The Argus II device (Second Sight Medical Products) is the only FDA-approved epiretinal implant at this time. In 2002, Argus I, the first iteration of the device, which had 16 microelec­trodes, was tested on human subjects who were enrolled in a phase 1 clinical trial.

Apr 9, 2020 · Objective: The Argus I implant is a first-generation epiretinal prosthesis approved for an investigational clinical trial in the U.S. Its successor, the Argus II implant, has a higher electrode density for increased spatial resolution and covers a larger retinal area to accommodate a wider visual angle.

Feb 15, 2022 · The clinical trials of the first-generation Argus I (with a 16-electrode array) and the subsequent Argus II retinal implant (with a 60-pixel array) resulted in European regulatory approval in 2011 ...

On February 14, 2013, the US Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device to treat adults with advanced retinitis pigmentosa (RP).

Artificial retina devices (e.g., the Argus II); Artificial iris devices (e.g., the CustomFlex Artificial Iris) for anterior segment reconstruction, and the treatment of aniridia, post-operative or traumatic aphakia, and other iris defects.

Purpose : The Argus I (Second Sight Medical Products) retinal implant, containing an array of 16 electrodes, is the first-generation epiretinal prosthesis approved for investigational clinical trials by the US FDA. The second-generation Argus II implant containing 60 electrodes has received market approval in Europe and in the US.

Argus I was the first-generation prototype of an epiretinal implant manufactured by Second Sight Medical Products.